Companies ›Basic Materials ›PSYN.PSX

PSYN.PSX — PSX (Pakistan) Commodity Chemicals

Pakistan Synthetics Ltd

$92,00

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

12,3 %

ROE

-0,2 %

Net margin

-0,2 %

Debt / equity

1,06

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

Pakistan Synthetics Ltd is a chemical manufacturing company that produces commodity chemicals and generates revenue primarily through the sale of synthetic products.

Business. Pakistan Synthetics Ltd (PSYN.PSX) is a commodity chemicals manufacturer operating within the Basic Materials sector. The company is headquartered in Pakistan and is primarily listed on the Pakistan Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %

SectorBasic Materials

Business sectorChemicals

IndustryCommodity Chemicals

ActivityChemicals

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability→

-0,2 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning PSYN.

Sector rotation

Sector1D1Mvs mkt

Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to PSYN.PSX. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Pakistan Synthetics Ltd (PSYN.PSX) is a commodity chemicals manufacturer operating within the Basic Materials sector. The company is headquartered in Pakistan and is primarily listed on the Pakistan Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %

SectorBasic Materials

Business sectorChemicals

IndustryCommodity Chemicals

ActivityChemicals

AI synthesis

GENERATED

Pakistan Synthetics Ltd has a debt-to-equity ratio of 1.06, indicating a moderate reliance on debt financing, and a current ratio of 1.12, suggesting limited short-term liquidity cushion. The company's negative operating cash flow of PKR -1.93 billion and free cash flow of PKR -8.41 million highlight a liquidity challenge, with capital expenditures of PKR -132.28 million further straining cash reserves.

The company's profitability metrics are weak, with a return on equity of -0.21% and a return on assets of -0.08%, both significantly below the industry median for commodity chemicals. These figures indicate a failure to generate returns for shareholders or effectively utilize assets.

Revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks, particularly in Pakistan.

The company's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year and no forward-looking guidance provided. Historical revenue of PKR 4.45 billion is flat compared to prior periods, and no clear drivers of future expansion are identified.

The risk assessment highlights a medium liquidity risk due to negative net cash after subtracting total debt. While dilution risk is currently low, the company's negative net income of PKR 8.77 million and reliance on debt financing could pressure equity value in the future.

Recent filings and transcripts are not available in the provided data, so no specific events can be cited to inform the company's recent performance or strategic direction.

Key takeaways

Pakistan Synthetics Ltd is underperforming in profitability, with negative returns on equity and assets.
The company faces liquidity challenges, with negative operating and free cash flows.
Revenue is not diversified across segments or geographies, increasing exposure to regional risks.
Growth is stagnant, with no clear path to expansion or margin improvement.
Debt financing is a key component of the capital structure, but it is not yet a source of dilution risk.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation FY

Market price

$92,00

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

$4.26B

Net cashⓘ

-$4.51B

Current ratioⓘ

1.1

Debt / equityⓘ

1.1

ROAⓘ

-0.1%

ROEⓘ

-0.2%

Cash conversionⓘ

22036.0%

CapEx / revenueⓘ

-3.0%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin12,3 %Above P75

Net Margin-0,2 %Bottom quartile

ROE-0,2 %Bottom quartile

Capex / Rev-3,0 %Above median

D/E1,06Bottom quartile

Cash Conv220,36Best in class

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

Pakistan Synthetics Ltd Market data — financials · 2026-05-29

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

PSYN.PSXCanonical

PSX (Pakistan) · USD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation FY

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread